MIRA INFORM REPORT

 

 

Report Date :           

23.04.2012

 

IDENTIFICATION DETAILS

 

Name :

BOLAK CO., LTD.

 

 

Formerly Known As :

Bolak Hyangryo Industries Co., Ltd.

 

 

Registered Office :

307-1, Songsan-ri, Yanggam-myeon, Hwaseong-si, Gyeonggi-do, Korea, Zip Code 445-933

 

 

Country :

South korea

 

 

Financials (as on) :

31.12.2011

 

 

Date of Incorporation :

17.08.1959

 

 

Com. Reg. No.:

124-81-34203

 

 

Legal Form :

Listed Company

 

 

Line of Business :

Manufacture of Other Food Additive Products

 

 

No. of Employees :

119

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2012

 

Country Name

Previous Rating

                   (31.12.2011)                  

Current Rating

(31.03.2012)

South korea

a1

a1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


Basic

 

Company Name

BOLAK CO., LTD.

(Korean Company Name : “()보락”)

Registered Address

307-1, Songsan-ri, Yanggam-myeon, Hwaseong-si, Gyeonggi-do, Korea

Zip Code

445-933

Tel

+82-31-352-6455~9

Fax

+82-31-352-4341

E-mail

bolak@kita.net

Website

www.bolak.co.kr

Trading Address

307-1, Songsan-ri, Yanggam-myeon, Hwaseong-si, Gyeonggi-do, Korea

Tel

+82-31-352-6455~9

Fax

+82-31-352-4341

Other Address

Bukchang Bldg., 20-6, Bukchang-dong, Jung-gu, Seoul, Korea

Tel

+82-2-756-6011

Fax

+82-2-774-2291

Type

Export/Import

Industry

Manufacture of Other Food Additive Products

  Main Business

Flavors, Gum Base, Calcium Carboxymethylcellulose, Xylitol, Chocolate, Pharmaceutical Raw Materials, Natural Extracts

  Sub Business

Manufacture of Medicinal Chemicals and Antibiotics

Established (mm/dd/yyyy)

08/17/1959

The Subject owns the premises of registered HQ address.

 

 

Detailed Products

 

Activity

Detailed Products (UNSPSC)

Sell

Formulas and products for nutritional support(42231800)

Sell

Methylcellulose(51171612)

Sell

Food or drug or cosmetic safe FDC dyes(12171504)

Sell

Flavours or extracts(12164502)

Sell

Chewing gum(50161815)

Sell

Chocolate or chocolate substitute candy(50161813)

Buy

Edible vegetable or plant oils(50151513)

Buy

Trees and shrubs(10161500)

Buy

Aromatic or heterocyclic compounds(12352005)

Buy

Alcohols or its substitutes(12352104)

Buy

Biochemicals(12352200)

Buy

Inorganic acids(12352301)

Buy

Inorganic hydroxides(12352305)

Buy

Forestry byproducts(11121700)

Buy

Chemistry reagents or solutions(41116105)

Buy

Natural sugars or sweetening products(50161509)

 

CEO’s

 

Name

Chung Ki-Ryun

Date of Birth

09/27/1954

Title

President & CEO

Sex

Male

Nationality

Korean

 

 

Profiles

 

Capital (KRW)

11,980,000,000

Employees

119

Formation

Listed Company (Korea stock exchange : 002760) as of 11/30/1989

Bank Details

Shinhan Bank-Namdaemun Branch

Corporate Registered No.

134811-0004474

Business Registered No.

124-81-34203

Permit & Licenses

Int’l Trade No.: 973247

Shareholder Position

Name

Shares

%

CHUNG KI-RYUN

2,473,830

20.65

HONG YOUNG-SOON

559,205

4.67

CHUNG SOO-RYUN

1,504,010

12.55

KO HYE-RYUN

42,395

0.35

CHUNG HEE-RYUN

399,540

3.34

CHUNG WUI-RYUN

201,360

1.68

CHUNG HYE-JIN

157,950

1.32

CHUNG EUN-JIN

157,950

1.32

CHOI KYUNG-AE & OTHERS(1)

1,096,936

9.16

OTHERS

5,386,824

44.97

TOTAL

11,980,000

100.00

Company History

08/17/1959 Incorporated as Korea Nongsan Industries Co., Ltd.

06/22/1963 Changed company name to Bolak Hyangryo Industries Co., Ltd.

03/25/1989 Changed company name to the present name

 

 

 

 

Management

 

Job Description

Title

Name

Nationality

Date of Birth

Education

President & CEO

Mr.

Chung Ki-Ryun

Korean

1954.09.27

Korea University, Korea

Auditor

Mr.

Park Soon-Baik

Korean

1946.11.18

Seoul National University, Korea

Director

Mr.

Hwangbo Dae-Ho

Korean

1960.02.17

Pyungtaik University, Korea

Director

Mr.

Kim Byung-Cheol

Korean

1951.03.18

Dongkuk University, Korea

Outside Director

Mr.

Yoon Gui-Seob

Korean

1944.11.05

Kyunghee University, Korea

 

 

Financials

 

Year / Unit : KRW

Sales

Assets

Net Income

(*)2011

25,276,708,420

46,455,549,130

124,894,366

(*)2010

23,189,664,256

46,628,120,051

844,924,256

2009

21,537,274,398

31,590,700,608

463,709,364

2008

18,659,886,394

27,930,786,535

193,915,098

2007

15,065,090,271

27,273,636,075

-1,240,786,339

(*)2010 and 2011’s figures are based on the K-IFRS Accounting System.

 

 

Financial Description

 

Authorized Capital(KRW)

25,000,000,000

Paid-Up Capital(KRW)

11,980,000,000

Total Issued Shares

11,980,000

 

 

Balance Sheet

 

Unit : Korean Won

As of 12/31/2011

As of 12/31/2010

As of 12/31/2009

Total Assets

46,455,549,130

46,628,120,051

 

Current Assets

15,706,221,964

15,119,091,188

 

Cash & Cash Equivalents

1,048,920,288

1,372,328,951

 

Trade Receivables & Other Receivables

6,157,988,846

6,488,912,290

 

Inventories

8,464,974,469

7,140,982,283

 

Income Taxes

2,260,850

3,419,750

 

Other Current Assets

32,077,511

113,447,914

 

Non-Current Assets

30,749,327,166

31,509,028,863

 

Non-Current Financial Instruments

156,972,240

79,324,080

 

Long-Term Trade Receivables & Other Receivables

751,539,782

805,559,497

 

Marketable Financial Instruments

830,660,595

819,311,743

 

Tangibles

22,543,239,243

23,100,373,049

 

Intangibles

273,325,957

294,754,735

 

Investment_Real Estates

6,164,957,654

6,405,303,990

 

Other Non-Current Assets

28,631,695

4,401,769

 

Total Liabilities

9,594,390,152

9,748,267,566

 

Current Liabilities

4,279,497,360

4,577,621,805

 

Trade Payables & Other Payables

2,643,886,416

2,931,017,458

 

Short-Term Borrowings

1,574,800,000

1,562,700,000

 

Other Current Liabilities

60,810,944

83,904,347

 

Non-Current Liabilities

5,314,892,792

5,170,645,761

 

Long-Term Borrowings

139,900,000

214,700,000

 

Confirmed Salaries

2,120,954,315

1,769,440,778

 

Deferred Income Tax Credit

3,054,038,477

3,186,504,983

 

Capital Stock

11,980,000,000

11,980,000,000

 

Capital Surplus

10,536,389,764

10,536,389,764

 

Others

14,040,666,325

13,607,550,909

 

Profit Surplus

304,102,889

755,911,812

 

Total Equity

36,861,158,978

36,879,852,485

 

Liab. & Shareholder’s Equity

46,455,549,130

46,628,120,051

 

 

 

Income Statement

 

Unit : Korean Won

As of 12/31/2011

As of 12/31/2010

As of 12/31/2009

Sales

25,276,708,420

23,189,664,256

 

Cost of Sold Goods

20,913,695,658

18,427,984,396

 

Gross Profit

4,363,012,762

4,761,679,860

 

Selling & Admin. Expenses

3,900,820,395

4,021,118,587

 

Operating Income

462,192,367

740,561,273

 

Other Operating Income

512,776,449

452,535,448

 

Other Operating Expenses

508,729,566

686,615,487

 

Finance Income

38,388,852

44,327,845

 

Finance Expenses

574,709,045

11,487,495

 

Income Before Taxes

-70,080,943

539,321,584

 

Income Taxes Expenses

194,975,309

305,602,672

 

Net Income

124,894,366

844,924,256

 

 

 

Cash Flows

 

Unit : Korean Won

As of 12/31/2011

As of 12/31/2010

As of 12/31/2009

Operating Activities Cash Flows

784,278,237

1,709,879,513

 

Net Income

124,894,366

844,924,256

 

Adjustment

682,796,150

814,529,406

 

Interests Received

11,084,063

42,386,597

 

Interests Paid

-36,723,992

-11,829,896

 

Dividends Received

1,068,750

570,000

 

Income Taxes

1,158,900

19,299,150

 

Cash Flows from Investing

-685,586,900

-775,666,394

 

Cash Flows from Financing

-422,100,000

-1,273,308,000

 

Increase/Decrease in Cash

-323,408,663

-339,094,881

 

Cash at the Beginning of Year

1,372,328,951

1,713,186,057

 

Cash at the End of Year

1,048,920,288

1,372,328,951

 

 

 

Products, Technologies, Services Description

 

Main Products & Services

Flavors, Gum Base, Calcium Carboxymethylcellulose, Xylitol, Chocolate, Pharmaceutical Raw Materials, Natural Extracts

 

 

Trade Partners & Competitors

 

Customers

DONGA PHARMACEUTICAL CO.,LTD.(110111-0017990 )

HAITAI CONFECTIONERY & FOODS CO., LTD.(161511-0044225)

ORION CORP.(110111-0004690)

LG HOUSEHOLD & HEALTH CARE LTD.(110111-2208000)

Competitors

KOREA CARRAGHEEN CO., LTD.

RM. 1022, HAENAM BLDG. ANNEX, 21, BUKCHANG-DONG, JUNG-GU, SEOUL, KOREA

TEL:+82-2-773-6501  FAX:+82-2-774-9740

 

CHEONG DO AGAR AGAR MFG. CO., LTD.

385, SORA-RI, HWAYANG-EUP, CHEONGDO-GUN, GYEONGSANGBUK-DO, KOREA

TEL:+82-54-372-7701~3  FAX:+82-54-372-7705

 

FINE AGAR AGAR CO., LTD.

579-52, WONYUL-RI, GEUMSEONG-MYEON, DAMYANG-GUN, JEOLLANAM-DO, KOREA

TEL:+82-61-383-0345  FAX:+82-61-383-2555

 

 

Related Parties

(Subsidiaries, Joint-Venture & Affiliates)

 

Affiliates

NAM YUNG COMMERICIAL CO., LTD.(110111-0014152)

HWASAN DEVELOPMENT CO., LTD.(134511-0007367)

BIO & GENE CO., LTD.(110111-1466261)

 

 


Sales by Region

(Activity & Markets)

 

Sales/ Unit : KRW

2011

2010

2009

Export

2,654,075,385

2,400,591,106

3,233,778,849

Domestic

22,622,633,035

20,789,073,150

18,303,495,549

Total

25,276,708,420

23,189,664,256

21,537,274,398

The Subject imports from Japan.

 

 

Court Action

 

No.

 

 

News Clipping

 

--

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.51.99

UK Pound

1

Rs.83.54

Euro

1

Rs.63.40

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.